Position in NVO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,323,603
+$2,090,226 QoQ
Shares Held
48,469
+2372.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#352
of 1,348 holders
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pine Valley Investments Ltd Liability Co holds $80,398,401 across 12 Drug Manufacturers - General names. NVO ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
116,193 | $29,509,536 | |
| 2 | ABBV |
AbbVie Inc.
|
72,077 | $18,137,456 | |
| 3 | LLY |
ELI LILLY & Co
|
10,622 | $12,740,346 | |
| 4 | MRK |
Merck & Co., Inc.
|
54,242 | $6,970,097 | |
| 5 | PFE |
Pfizer Inc
|
150,761 | $3,630,324 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
43,011 | $2,478,293 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
48,469 | $2,323,603 | |
| 8 | AMGN |
Amgen Inc
|
4,490 | $1,625,918 |
All Filings in NVO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,323,603 | 48,469 | Shares | Sole | 2026-07-24 | |
| 2024-09-30 | $233,377 | 1,960 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $281,911 | 1,975 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $222,260 | 1,731 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||